Literature DB >> 2988752

Prognostic histologic features of resected small hepatocellular carcinoma (HCC) in Taiwan. A comparison with resected large HCC.

H C Hsu, J C Sheu, Y H Lin, D S Chen, C S Lee, L Y Hwang, R P Beasley.   

Abstract

The morphologic features and their prognostic significance were analyzed in 83 surgically resected hepatocellular carcinomas (HCC): 44 of them were of less than or equal to 5 cm in diameter and 39 were larger. This study demonstrated a high prevalence of tumor capsule in both small and large HCCs, 86.4% and 84.6%, respectively. In small HCC, the capsule formation was significantly higher in the liver with cirrhosis (96.9%, or 31/32) than without (58.3%, or 7/12) (P less than 0.003). In both small and large HCCs, the most important histologic parameter influencing the tumor recurrence was the liver invasion. In the small but not in the large HCC, the invasion through the capsule also correlated well with recurrence (P less than 0.05). None of the 19 patients whose HCC were confined by a tumor capsule and did not invade the liver, had a recurrence during the 10 months or longer follow-up period. The significantly more favorable outcome of smaller HCC was related to the lower frequencies of liver invasion (P less than 0.001), portal vein involvement (P less than 0.01), and satellite formation (P less than 0.01). Tumor recurrence did not correlate with the tumor grading, presence of clear cells, liver cell dysplasia, or host inflammatory response. The HBsAg positivity in tumor cells was significantly higher in small (40.9%, or 18/44) than in large HCC (10.3%, or 4/39), suggestive of a gradual loss of the cytoplasmic expression of HBsAg in the tumor cells during the growth of HCC.

Entities:  

Mesh:

Year:  1985        PMID: 2988752     DOI: 10.1002/1097-0142(19850801)56:3<672::aid-cncr2820560340>3.0.co;2-v

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience.

Authors:  E C Lai; I O Ng; K T You; S T Fan; F P Mok; E S Tan; J Wong
Journal:  World J Surg       Date:  1991 Sep-Oct       Impact factor: 3.352

2.  Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.

Authors:  Takahiro Ezaki; Toru Ikegami; Takashi Maeda; Tomomi Yamada; Teruyoshi Ishida; Makoto Hashizume; Yoshihiko Maehara
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  Morphological clues for the diagnosis of small hepatocellular carcinomas.

Authors:  F Kondo; N Hirooka; K Wada; Y Kondo
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

4.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis.

Authors:  T Nagao; S Inoue; S Goto; T Mizuta; Y Omori; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1987-01       Impact factor: 12.969

Review 5.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

6.  Hepatectomy for large hepatocellular carcinoma: the optimal resection margin.

Authors:  E C Lai; I O Ng; K T You; T K Choi; S T Fan; F P Mok; J Wong
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

7.  The pathological basis of resection margin for hepatocellular carcinoma.

Authors:  E C Lai; K T You; I O Ng; T W Shek
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

8.  Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma.

Authors:  Satoru Hagiwara; Masatoshi Kudo; Toshihiko Kawasaki; Miki Nagashima; Yasunori Minami; Hobyung Chung; Toyokazu Fukunaga; Masayuki Kitano; Tatsuya Nakatani
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

9.  Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells.

Authors:  En-Hua Xiao; Jing-Qing Li; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

10.  Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Authors:  M Paroli; G Carloni; A Franco; G De Petrillo; E Alfani; A Perrone; V Barnaba
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.